概述
Jacob Thaysen 是 Illumina 首席执行官，曾在生命科学工具和诊断行业担任高级管理职务。
职业经历
Thaysen 在加入 Illumina 前曾任 Agilent Technologies 生命科学与应用市场集团负责人，具有实验室仪器、诊断和生命科学市场经验。
相关议题
他领导的 Illumina 面对全球基因测序市场竞争、监管审查和中国市场准入问题。
关联实体与概念
来源与参考
-
Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer — Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer [...] SAN DIEGO, Sept. 5, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Di
-
Illumina names Agilent’s Jacob Thaysen as its next CEO | MedTech Dive — # Illumina names Agilent’s Jacob Thaysen as its next CEO [...] The appointment comes less than three months after former CEO Francis deSouza stepped down following a proxy battle. [...] Illumina has selected Jacob Thaysen as its new CEO. Permission granted by
-
Ex99 1.htm — Illumina’s Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer [...] SAN DIEGO, September 5, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board o
-
raw/articles/笔记侠-特朗普访华CEO名单-2026.md— 该文章是本实体页创建或更新的来源之一。